Abilify and Fragmin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Abilify (aripiprazole) and Fragmin (dalteparin sodium). Common drug interactions include altered state of consciousness among females and dizziness among males.

The phase IV clinical study analyzes what interactions people have when they take Abilify and Fragmin. It is created by eHealthMe based on reports of 17 people who take the same drugs from the FDA, and is updated regularly.

What is Abilify?

Abilify has active ingredients of aripiprazole. It is often used in depression. eHealthMe is studying from 101,454 Abilify users. Check the latest studies of Abilify.

What is Fragmin?

Fragmin has active ingredients of dalteparin sodium. It is often used in deep venous thrombosis. eHealthMe is studying from 11,999 Fragmin users. Check the latest studies of Fragmin.



On Jul, 15, 2026

17 people who take Abilify and Fragmin together, and have interactions are studied.

Abilify and Fragmin drug interactions.

What are the common drug interactions of Abilify and Fragmin, by gender? *:

female:

  1. Altered state of consciousness (altered state of mind)
  2. Angioedema (rapid swelling of the dermis)
  3. Confusional state
  4. Erythema multiforme (a type of hypersensitivity reaction)
  5. Gangrene (body tissue dies)
  6. Hallucination (an experience involving the perception of something not present)
  7. Mental disorder (a psychological term for a mental or behavioural pattern or anomaly that causes distress or disability)
  8. Nasal ulcer (ulcer of nose)
  9. Oral disorder (mouth disease)
  10. Rash

male:

  1. Dizziness
  2. Fall
  3. Insomnia (sleeplessness)
  4. Maternal exposure during pregnancy (use of substance during pregnancy)
  5. Nervousness
  6. Platelet count decreased
  7. Pyrexia (fever)
  8. Renal failure acute (rapid kidney dysfunction)
  9. Restlessness (not able to rest)
  10. Agitation (state of anxiety or nervous excitement)

What are the common drug interactions of Abilify and Fragmin, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Angioedema (rapid swelling of the dermis)
  2. Erythema multiforme (a type of hypersensitivity reaction)
  3. Mental disorder (a psychological term for a mental or behavioural pattern or anomaly that causes distress or disability)
  4. Nasal ulcer (ulcer of nose)
  5. Oral disorder (mouth disease)
  6. Rash
  7. Rash maculo-papular (red area on the skin that is covered with small confluent bumps)

30-39:

  1. Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
  2. Diabetes mellitus inadequate control
  3. Haemolytic anaemia (anaemia due to haemolysis)

40-49:

  1. Ileus paralytic (obstruction of the intestine due to paralysis of the intestinal muscles)
  2. Intestinal perforation (complete penetration of the wall of the intestine)

50-59:

  1. Dizziness
  2. Fall
  3. Restlessness (not able to rest)
  4. Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)
  5. Oedema peripheral (superficial swelling)
  6. Pneumonia
  7. Skin infection
  8. Thrombosis (formation of a blood clot inside a blood vessel)
  9. Eye pruritus (eye itching)
  10. Headache (pain in head)

60+:

  1. Agitation (state of anxiety or nervous excitement)
  2. Altered state of consciousness (altered state of mind)
  3. Delirium (wild excitement)
  4. Delusion (a false belief or opinion)
  5. Depressed level of consciousness
  6. Energy increased
  7. Fatigue (feeling of tiredness)
  8. General physical health deterioration (weak health status)
  9. Haemolytic uraemic syndrome (blood clotting disease caused by e. coli infection, birth control pills, pneumonia, medications, and more)
  10. Insomnia (sleeplessness)

What are the existing conditions these people have? *

  1. Bipolar Disorder (mood disorder): 4 people, 23.53%
  2. Delusion (a false belief or opinion): 2 people, 11.76%
  3. Schizophrenia (a mental disorder characterized by a breakdown of thought processes): 1 person, 5.88%
  4. Pain: 1 person, 5.88%
  5. Ovarian Cancer (cancer of ovary): 1 person, 5.88%
  6. Mania (a state of abnormally elevated or irritable mood): 1 person, 5.88%

* Approximation only. Some reports may have incomplete information.

Do you take Abilify and Fragmin?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Abilify and Fragmin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Abilify:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Fragmin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Abilify and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Fragmin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on aripiprazole and dalteparin sodium (the active ingredients of Abilify and Fragmin, respectively), and Abilify and Fragmin (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: